Healthcare Law Newswire (Page 7)

Healthcare Law Newswire (Page 7)

Comprehensive Real-Time News Feed for Healthcare Law. (Page 7)

Results 121 - 140 of 79,357 in Healthcare Law

  1. Sangamo Announces Presentation At The Deutsche Bank 41st Annual Health Care ConferenceRead the original story

    Thursday | BioSpace

    The presentation will be archived on the Sangamo website for two weeks after the event. About Sangamo Sangamo BioSciences, Inc. is focused on Engineering Genetic CuresA for monogenic and infectious diseases by deploying its novel DNA-binding protein technology platform in therapeutic genome editing and gene regulation.

    Comment?

  2. Therabron Receives FDA Fast Track Designation For Rhcc10 For The...Read the original story

    Thursday | BioSpace

    Therabron Therapeutics' lead biopharmaceutical product candidate is a proprietary preparation of recombinant human CC10 protein which has potential clinical applications, based on its potent anti-inflammatory properties, in a variety of respiratory diseases. CG100, the company's lead compound based on rhCC10 and intended to prevent chronic lung disease in neonates, is currently in a Phase 2 clinical trial enrolling 88 preterm infants.

    Comment?

  3. Stryker Coughs Up $52 Million for Stanmore ImplantsRead the original story

    Thursday | BioSpace

    April 29, 2016 - Stryker Corporation announced today it has acquired Stanmore Implants Worldwide Limited from SIW Holdings Limited in an all cash transaction for A 35.6 million. Stanmore Implants is an innovative orthopaedic business focused on serving the needs of surgeons that treat adult and juvenile orthopaedic oncology.

    Comment?

  4. European Medicines Agency Issues Positive Opinion For The Use Of...Read the original story

    Thursday | BioSpace

    The positive CHMP recommendation follows the March 4, 2016 U.S. Food and Drug Administration approval of IMBRUVICA for the first-line treatment of patients with CLL.1 If approved by the European Commission , this would be the fifth treatment indication for IMBRUVICA in the EU to date. among men and women is approximately 5.87 and 4.01 cases per 100,000 persons per year, respectively.2 An expansion of the CLL indication in would mean a larger number of CLL patients, in addition to those with the genetic mutations del 17p or TP53, could initiate their treatment with a safe and effective oral alternative option to chemotherapy, rather than having to wait until they have become relapsed or refractory on another treatment option.

    Comment?

  5. BioDelivery Announces Acceptance Of An Abstract To The On The Impact...Read the original story

    Thursday | BioSpace

    BioDelivery Announces Acceptance Of An Abstract To The International Conference On Opioids On The Impact Of A State Formulary Conversion To BUNAVAIL /PRNewswire/ -- BioDelivery Sciences International, Inc. announced the acceptance of an abstract for presentation at the International Conference on Opioids, which takes place , Massachusetts. The abstract entitled, Reduced Buprenorphine/Naloxone Prescriptions Dispensed in a State Medicaid Population Following Formulary Conversion from Suboxone to Bunavail: Implications for Potential Diversion, has been accepted for a poster presentation to take place on Monday, June 6. Dr. The International Conference on Opioids is presented by the Journal of Opioid Management.

    Comment?

  6. LUNGevity Launches First-Of-Its-Kind Lung Cancer Program To Enhance Clinical Trial ParticipationRead the original story

    Thursday | BioSpace

    The program is the first of its kind for lung cancer patients and was created to offer one-on-one mentoring to help patients considering trial participation by answering questions, providing an understanding of the clinical trial process, and framing questions to ask their doctors. The number of clinical trials for lung cancer treatments has grown exponentially in recent years, giving patients new treatment options and resulting in new drug approvals.

    Comment?

  7. Women's health advocates protest at lawmaker's officeRead the original story w/Photo

    Thursday | The Orlando Sentinel

    Women's health advocates protesting a law restricting funds to Planned Parenthood attempt to deliver a statement to state Rep. Bob Cortes's office Thursday, but the door was locked Women's health advocates protesting a law restricting funds to Planned Parenthood attempt to deliver a statement to state Rep. Bob Cortes's office Thursday, but the door was locked A coalition of women's health advocates protested outside the office of state Rep. Bob Cortes in Maitland on Thursday, calling him a "hypocrite" for backing a law they say would close women's health clinics throughout the state. The group of about a dozen women attempted to deliver a written statement to the office, but the door was locked.

    Comment?

  8. House gives initial OK to moving $700 million fee out from under TABORRead the original story w/Photo

    Thursday | Brush News-Tribune

    A bill to free up $700 million in the state budget for transportation and other state needs - at the expense of taxpayers who would otherwise get a refund - got initial approval from the Colorado House Thursday. Democrats hope to reclassify the 7-year-old hospital provider fee as an "enterprise fund," which would move it out from under a revenue cap set by state's Taxpayer's Bill of Rights, which triggers refunds to taxpayers.

    Comment?

  9. Cruz gets Indiana governor's endorsementRead the original story w/Photo

    Thursday | WHDH

    In a setback for Donald Trump, Indiana's governor endorsed the front-runner's chief rival, Ted Cruz, on Friday, just days before the state's critical Republican primary contest. Indiana Gov. Mike Pence made his support for the Texas senator official during an afternoon radio interview, casting Cruz as "a principled conservative."

    Comment?

  10. Benchworks Celebrates 25 YearsRead the original story

    Wednesday Apr 27 | BioSpace

    Anniversary coincides with official unveiling of new headquarters. Chestertown, Maryland, April 27, 2016 - This year marks 25 years in business for Benchworks, a growing family of businesses dedicated to serving the life science industry through a wide range of top-quality services including marketing, creative, wholesale distribution and consulting.

    Comment?

  11. Should consumers be allowed to order their own lab tests?Read the original story w/Photo

    19 hrs ago | MarketWatch

    More Americans are taking control of their medical information, obtaining electronic records from their health-care providers so they can more easily keep track of their care and discuss it with their doctors. But originating health information through lab tests is still mostly under the control of doctors.

    Comment?

  12. Weekly Investment Analysts' Ratings Updates for MAXIMUSRead the original story w/Photo

    19 hrs ago | AmericanBankingNews.com

    Several brokerages have updated their recommendations and price targets on shares of MAXIMUS in the last few weeks: 4/19/2016 - MAXIMUS was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. According to Zacks, "MAXIMUS, Inc. is an extremely dynamic and complex organization that offers government and industry a range of unique services, products, and solutions.

    Comment?

  13. Keryx Biopharmaceuticals (KERX) Sees Significant Drop in Short InterestRead the original story w/Photo

    20 hrs ago | AmericanBankingNews.com

    Keryx Biopharmaceuticals was the target of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 19,885,945 shares, a decrease of 12.2% from the March 31st total of 22,647,968 shares, AnalystRatingsNetwork.com reports.

    Comment?

  14. Commentary: Winner will have awful honeymoonRead the original story

    20 hrs ago | The Daily Record

    The presidential primaries are a long way from over, but they've already produced an unhappy paradox: Both parties appear headed toward nominating the two most unpopular candidates in the country. Donald Trump, the Republican front-runner, has accomplished an unprecedented feat: More than two-thirds of voters say they can't stand him.

    Comment?

  15. Ag Groups Concerned About USDA's Biotech Regulations ChangesRead the original story

    20 hrs ago | Agri Marketing

    AG GROUPS CONCERNED ABOUT USDA'S BIOTECH REGULATIONS CHANGES Apr. 29, 2016 Feedstuffs magazine reports: Several agricultural groups have submitted comments voicing concerns to the U.S. Department of Agriculture regarding the Animal & Plant Health Inspection Service's proposed revisions to biotechnology crop regulations. In February, APHIS announced its intent to conduct a programmatic economic impact study as part of a comprehensive study of its Part 340 regulations of biotech crops.

    Comment?

  16. Group: Amend abortion pill suitRead the original story w/Photo

    20 hrs ago | Arkansas Online

    In light of the U.S. Food and Drug Administration's decision late last month to update its protocol for administering medication abortions, Planned Parenthood is asking to amend its lawsuit challenging an Arkansas law.

    Comment?

  17. Will Obamacare Collapse Before Obama Leaves Office?Read the original story w/Photo

    20 hrs ago | Accuracy In Media

    The typical mainstream media playbook stipulates that all opposition to liberal policies must be reported as originating with Republicans or conservatives. Thus, The Hill recently cast opposition to Obamacare as Republican presidential partisanship.

    Comment?

  18. Centene Corp (CNC) - Investment Analysts' Recent Ratings ChangesRead the original story w/Photo

    20 hrs ago | AmericanBankingNews.com

    According to Zacks, "Centene Corporation provides managed care programs and related services to individuals receiving benefits under Medicaid, including Supplemental Security Income, and the State Children's Health Insurance Program. " 4/25/2016 - Centene Corp is now covered by analysts at Cowen and Company.

    Comment?

  19. Pulse8 Presents Reconcili8a , the Most Flexible and Reliable Submissions and Reconciliation SolutionRead the original story w/Photo

    21 hrs ago | PRWeb

    Pulse8 understands that the volume of data required for today's government programs, along with their complex and ever-changing regulations, can be overwhelming. Reconcili8 eases those burdens with end-to-end submission and reconciliation processes that ensure regulatory compliance and improve risk score accuracy.

    Comment?

  20. Anthem trumps Street 1Q forecasts, reaffirms 2016 guidanceRead the original story w/Photo

    21 hrs ago | The Beaumont Enterprise

    In this Thursday, Feb. 5, 2015, file photo, the Anthem logo hangs at the health insurer's corporate headquarters in Indianapolis.

    Comment?